Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Reinoud J B Blaisse"'
Autor:
Koji Kawai, Satoshi Nagamori, Katherine M Bell-McGuinn, Cristiano Ferrario, Wen Pin Su, Isabel Syndikus, Aude Flechon, Georgios Gakis, Timothy Dudley Clay, Leticia Vazquez Cortés, Ronald de Wit, Florence Joly, Bozena Sikora-Kupis, Sergio Bracarda, Astra M. Liepa, Annemie Rutten, Daniel P. Petrylak, Su Peng Yeh, Annamaria Zimmermann, Sameera R. Wijayawardana, Mutsushi Kawakita, Siobhan Ng, Thean Hsiang Tan, Chikara Ohyama, Yu Jung Kim, Yuriy Golovko, Dimitrios Mavroudis, Jian Ri Li, Reinoud J. B. Blaisse, Mustafa Erman, Francesca Russo, Catherine Becht, Anghel Adrian Udrea, Robert Huddart, Syed A. Hussain, Fransiscus L.G. Erdkamp, Satoshi Fukasawa, Francesco Massari, Motohide Uemura, Boris Alekseev, Irfan Cicin, Se Hoon Park, Marcello Tucci, Lajos Géczi, Maureen J.B. Aarts, Yu Li Su, Fumimasa Fukuta, Hyo Jin Lee, Wolfgang Schultze-Seemann, Alexandra Drakaki, Hakan Harputluoglu, Xavier Garcia del Muro, Santhanam Sundar, Avivit Peer, Herlinde Dumez, William E. Lawler, Juan Ignacio Delgado Mignorance, Naveed Sarwar, Jeanny B. Aragon-Ching, Benjamin T. Herms, Fredrik Laestadius, Nobuaki Matsubara, Ivan Sinielnikov, Cora N. Sternberg, Hiroyuki Nishiyama, Piotr Tomczak, Brigitte Laguerre, Rebecca R. Hozak, Vasilis Karavasilis, Christina A. Schwentner, Hiroyuki Tsunemori, Masayoshi Nagata, Igor Bondarenko, Andrea Necchi, Yen Chuan Ou, Scott T. Tagawa, Constance Thibault, Richard A. Walgren, Akira Yokomizo, Evan Y. Yu, Alejo Rodriguez-Vida, Sufia Safina, Ulka N. Vaishampayan, János Révész, Aristotelis Bamias, Jae-Lyun Lee, Chien Liang Lin, Thomas W. Flaig, Roman Fomkin, Petr Alexandrovich Karlov, Joanna Wojcik-Tomaszewska, Junichi Inokuchi, Wataru Obara, Haralambos Kalofonos, John D. Hainsworth, Marc-Oliver Grimm, Thomas Eugene Lowe, Pablo Gajate Borau, Simon J. Crabb, Lisa Sengeloev, Junji Yonese, Simon Chowdhury, Elizabeth Jane Hovey, Daniel Castellano, Peter Istvan Acs, Chia-Chi Lin, Claudia Lorena Urzua Flores, Jean-Pascal Machiels, Kim N. Chi, Takahiro Osawa, Nobuo Shinohara, Daniel Kejzman, Günter Niegisch, David Sarid, Yuksel Urun, Yun Gyoo Lee, Oday Hamid, Alina Amalia Herzal, Michael Schenker, Eli Rosenbaum, Enrique Grande, Raya Leibowitz-Amit, Naoto Miyajima, Michiel S. van der Heijden, Shinichi Yamashita, Susanna Yee Shan Cheng, Kazuo Nishimura, Sun Young Rha, Thomas Powles, Hasan Şenol Coşkun, Jens Bedke, Ivor J. Percent, Christos Papandreou, James K. Schwarz, Masafumi Oyama, Giorgio V. Scagliotti, Chong-Xian Pan, Yoshihiko Tomita, Giampaolo Tortora, Stéphane Culine, Suet Lai Shirley Wong, Andrey Semenov, Jennifer L. Cultrera, Niels Viggo Jensen, Michael Stöckle, Katsuyoshi Hashine
Publikováno v:
Lancet Oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Group
Background Ramucirumab-an IgG1 vascular endothelial growth factor receptor 2 antagonistplus docetaxel was previously reported to improve progression-free survival in platinum-refractory, advanced urothelial carcinoma. Here, we report the secondary en
Autor:
Berend J van der Wilk, Hanneke W. M. van Laarhoven, Maurice J.C. van der Sangen, Janny G. Reinders, Cornelis J. A. Punt, Geke A. P. Hospers, J. Jan B. van Lanschot, Bas P. L. Wijnhoven, Ernst Jan Spillenaar Bilgen, Mark I. van Berge Henegouwen, Anna H.M. Piet, Pieter van Hagen, John T. M. Plukker, Fiebo J. W. ten Kate, Henk M.W. Verheul, Hugo W. Tilanus, Joel Shapiro, Ewout W. Steyerberg, Caroline M. van Rij, Grard A. P. Nieuwenhuijzen, Ben M Eyck, Geert-Jan Creemers, Tom Rozema, Ate van der Gaast, Reinoud J. B. Blaisse, Johannes J. Bonenkamp, Miguel A. Cuesta, Maarten C.C.M. Hulshof, Jannet C. Beukema, Olivier R. Busch
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 1995-2004
Journal of clinical oncology, 39(18), 1995-2004. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(18), 1995-2004. LIPPINCOTT WILLIAMS & WILKINS
Eyck, B M, van Lanschot, J J B, Hulshof, M C C M, van der Wilk, B J, Shapiro, J, van Hagen, P, Henegouwen, M I V B, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R, Creemers, G-J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van der Sangen, M J C, Rozema, T, Ten Kate, F J W, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W & van der Gaast, A 2021, ' Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 18, pp. 1995-+ . https://doi.org/10.1200/JCO.20.03614
Journal of Clinical Oncology, 39, 18, pp. 1995-2004
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-2004. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-2004. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 39, 1995-2004
Journal of clinical oncology, 39(18), 1995-2004. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(18), 1995-2004. LIPPINCOTT WILLIAMS & WILKINS
Eyck, B M, van Lanschot, J J B, Hulshof, M C C M, van der Wilk, B J, Shapiro, J, van Hagen, P, Henegouwen, M I V B, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R, Creemers, G-J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van der Sangen, M J C, Rozema, T, Ten Kate, F J W, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W & van der Gaast, A 2021, ' Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 18, pp. 1995-+ . https://doi.org/10.1200/JCO.20.03614
Journal of Clinical Oncology, 39, 18, pp. 1995-2004
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-2004. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(18), 1995-2004. AMER SOC CLINICAL ONCOLOGY
PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for esophageal cancer followed by surgery study (CROSS) has become a standard of care for patients with locally advanced resectable esophageal or junctional cancer. We aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd6a9a534748f1216df055340ab0136
https://hdl.handle.net/1887/3277522
https://hdl.handle.net/1887/3277522
Autor:
Geke A. P. Hospers, Daan Nieboer, Bas P. L. Wijnhoven, Anna H.M. Piet, Berend J van der Wilk, Katharina Biermann, Joel Shapiro, Mark I. van Berge Henegouwen, Ben M Eyck, Henk M.W. Verheul, Hanneke W. M. van Laarhoven, Maarten C.C.M. Hulshof, Olivier R. Busch, Janny G. Reinders, Maurice J.C. van der Sangen, Grard A. P. Nieuwenhuijzen, Caroline M. van Rij, Pieter van Hagen, Ate van der Gaast, Fiebo J. W. ten Kate, Johannes J. Bonenkamp, Miguel A. Cuesta, Ernst Jan Spillenaar Bilgen, Geert-Jan Creemers, Tom Rozema, Reinoud J. B. Blaisse, Jannet C. Beukema, Cornelis J. A. Punt, Herman van Dekken, Hugo W. Tilanus, J. Jan B. van Lanschot, John T. M. Plukker
Publikováno v:
Diseases of the Esophagus. 32
Aim To report the long term results of the CROSS trial with a minimum follow-up of 10 years. Background Neoadjuvant chemoradiotherapy according to the Dutch randomised controlled ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CRO
Autor:
J. Jan B. van Lanschot, Jannet C. Beukema, Herman van Dekken, Janny G. Reinders, Olivier R. Busch, Fiebo J.W. ten Kate, Bo Jan Noordman, Mathilde G. E. Verdam, Johannes J. Bonenkamp, Grard A. P. Nieuwenhuijzen, Hugo W. Tilanus, Geert-Jan Creemers, Pieter van Hagen, Mark I. van Berge Henegouwen, Tom Rozema, Mirjam A. G. Sprangers, Cornelis J. A. Punt, John T. M. Plukker, Geke A. P. Hospers, Ate van der Gaast, Reinoud J. B. Blaisse, Maarten C.C.M. Hulshof, Bas P. L. Wijnhoven, Katharina Biermann, Anna H.M. Piet, Henk M.W. Verheul, Hanneke W. M. van Laarhoven, Ernst Jan Spillenaar Bilgen, Ewout W. Steyerberg, Miguel A. Cuesta, Maurice J.C. van der Sangen, Sjoerd M. Lagarde, Caroline M. van Rij
Publikováno v:
Journal of Clinical Oncology, 36, 3, pp. 268-275
Noordman, B J, Verdam, M G E, Lagarde, S M, Hulshof, M C C M, van Hagen, P, van Berge Henegouwen, M I, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R, Ten Kate, F J W, Creemers, G-J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Spillenaar Bilgen, E J, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W, van der Gaast, A, Sprangers, M A G & van Lanschot, J J B 2018, ' Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer : Results From the Randomized CROSS Trial ', Journal of Clinical Oncology, vol. 36, no. 3, pp. 268-275 . https://doi.org/10.1200/JCO.2017.73.7718
Journal of Clinical Oncology, 36(3), 268-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36(3), 268-279. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 36(3), 268-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 268-275
Journal of Clinical Oncology, 36(3), 268-275. American Society of Clinical Oncology
JOURNAL OF CLINICAL ONCOLOGY
JOURNAL OF CLINICAL ONCOLOGY, 36(3), 268-275
Noordman, B J, Verdam, M G E, Lagarde, S M, Hulshof, M C C M, van Hagen, P, van Berge Henegouwen, M I, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R, Ten Kate, F J W, Creemers, G-J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Spillenaar Bilgen, E J, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W, van der Gaast, A, Sprangers, M A G & van Lanschot, J J B 2018, ' Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer : Results From the Randomized CROSS Trial ', Journal of Clinical Oncology, vol. 36, no. 3, pp. 268-275 . https://doi.org/10.1200/JCO.2017.73.7718
Journal of Clinical Oncology, 36(3), 268-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36(3), 268-279. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 36(3), 268-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 36, 268-275
Journal of Clinical Oncology, 36(3), 268-275. American Society of Clinical Oncology
JOURNAL OF CLINICAL ONCOLOGY
JOURNAL OF CLINICAL ONCOLOGY, 36(3), 268-275
Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esophageal or junctional cancer who received neoadjuvant chemoradiotherapy (nCRT) followed by surgery or surgery alone. Secondary aims were to examine the e
Autor:
Andrzej Piwowar, Fransje Aa Valster, Jeffrey P.B.M. Braak, Marije Ie Appels, Frits van Coevorden, Niels H Nielsen, Johanna E.A. Portielje, Jeroen Buijsen, Petra Flygare, Marije Slingerland, Nicole C.T. van Grieken, Jetske M. Meerum Terwogt, Maartje Los, Mattias Elmlund, Henk Boot, Rob L. H. Jansen, Johanna W. van Sandick, A. Haringhuizen, Johannes J. Bonenkamp, Harm van Tinteren, Edwin P.M. Jansen, Henk H. Hartgrink, Jaap De Boer, Anouk K. Trip, Ge Jpm Jonkers, Marie Louise Jespersen, Cecillia Lagerbäck, Per Edlund, Marco B Polée, Mats Perman, J (Hans)-Martin Mb Otten, Marjan A Van Dijk, Danny Houtsma, A (Bert) Jan Ten Tije, Arnold Baars, Olaf Jl Loosveld, Maud M. Geenen, Maarten C.C.M. Hulshof, Gerrit-Jan Veldhuis, Erik W Muller, Geert-Jan Creemers, Annelie Je Vulink, Quirijn A. J. Eijsbouts, Annerie Slot, Diane Grootenboers, Hein Putter, Ellen M Hendriksen, Maurice J.C. van der Sangen, Fabiënne A. R. M. Warmerdam, Tom Rozema, HA A. Maurits Swellengrebel, Henk K Van Halteren, Ate van der Gaast, Marcel Verheij, Richard Van Hilligersberg, Helene Hörberg, Pehr Lind, Annemieke Cats, Cornelis J.H. van de Velde, Jitty M Smit, Alex L. T. Imholz, Donald L. van der Peet, Aart Van Bochove, Henk M.W. Verheul, Adelheid Me Van der Torren-Conze, Frans L. G. Erdkamp, Dick Johan van Spronsen, Mark I. van Berge Henegouwen, Ernst Jan Spillenaar Bilgen, Johanna Mgh Van Riel, Marien O Den Boer, Hanneke W. M. van Laarhoven, Marjolein Em Rentinck, Ron C Rietbroek, Bengt Johansson, David Borg, Anders Johnsson, Aart Beeker, Reinoud J. B. Blaisse, Miriam Koopman, Daan Ten Bokkel Huinink, Karen J. Neelis, Elma Meershoek-Klein Kranenbarg, Djamila Boerma, Heleen M. Ceha, Bea C Tanis, Marie-Cecile Jc Legdeur, O Aart Van Dobbenburgh, Steven Vanhoutvin, Sjoerd Hovenga, Karolina Sikorska, Pètra M Braam, H Pieter van den Berg, Huub van der Mijle, Marianne Nordsmark, Bengt Glimelius
Publikováno v:
lancet oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: Both perioperative chemotherapy and postoperative chemoradiotherapy improve survival in patients with resectable gastric cancer from Europe and North America. To our knowledge, these treatment strategies hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21019f3b155741c37a17771cdb957cb
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html
Autor:
Johannes J. Bonenkamp, Maurice J.C. van der Sangen, Herman van Dekken, Grard A. P. Nieuwenhuijzen, Pieter van Hagen, Ernst Jan Spillenaar Bilgen, Hugo W. Tilanus, Ate van der Gaast, Caroline M. van Rij, Geke A. P. Hospers, Olivier R. Busch, Maarten C.C.M. Hulshof, Miguel A. Cuesta, Reinoud J. B. Blaisse, Bas P. L. Wijnhoven, Joel Shapiro, Anna H.M. Piet, Katharina Biermann, Fiebo J. W. ten Kate, Henk M.W. Verheul, Janny G. Reinders, Hanneke W. M. van Laarhoven, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, John T. M. Plukker, Jannet C. Beukema, Geert-Jan Creemers, Tom Rozema, Cornelis J. A. Punt
Publikováno v:
lancet oncology, 16(9), 1090-1098. Lancet Publishing Group
Lancet Oncology, 16, 9, pp. 1090-8
Lancet Oncology, 16(9), 1090-1098. Lancet Publishing Group
Lancet Oncology, 16, 1090-8
Shapiro, J, van Lanschot, J J B, Hulshof, M C C M, van Hagen, P, Henegouwen, M I V, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R C, Ten Kate, F J W, Creemers, G J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W & van der Gaast, A 2015, ' Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial ', Lancet Oncology, vol. 16, no. 9, pp. 1090-1098 . https://doi.org/10.1016/S1470-2045(15)00040-6
Lancet Oncology, 16(9), 1090-1098. ELSEVIER SCIENCE INC
Lancet Oncology, 16, 9, pp. 1090-8
Lancet Oncology, 16(9), 1090-1098. Lancet Publishing Group
Lancet Oncology, 16, 1090-8
Shapiro, J, van Lanschot, J J B, Hulshof, M C C M, van Hagen, P, Henegouwen, M I V, Wijnhoven, B P L, van Laarhoven, H W M, Nieuwenhuijzen, G A P, Hospers, G A P, Bonenkamp, J J, Cuesta, M A, Blaisse, R J B, Busch, O R C, Ten Kate, F J W, Creemers, G J M, Punt, C J A, Plukker, J T M, Verheul, H M W, Bilgen, E J S, van Dekken, H, van der Sangen, M J C, Rozema, T, Biermann, K, Beukema, J C, Piet, A H M, van Rij, C M, Reinders, J G, Tilanus, H W, Steyerberg, E W & van der Gaast, A 2015, ' Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial ', Lancet Oncology, vol. 16, no. 9, pp. 1090-1098 . https://doi.org/10.1016/S1470-2045(15)00040-6
Lancet Oncology, 16(9), 1090-1098. ELSEVIER SCIENCE INC
Item does not contain fulltext BACKGROUND: Initial results of the ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS) comparing neoadjuvant chemoradiotherapy plus surgery versus surgery alone in patients with squamous cell carc
Autor:
A, Koen Talsma, Joel, Shapiro, Caspar W N, Looman, Pieter, van Hagen, Ewout W, Steyerberg, Ate, van der Gaast, Mark I, van Berge Henegouwen, Bas P L, Wijnhoven, J Jan B, van Lanschot, Maarten C C M, Hulshof, Hanneke W M, van Laarhoven, Grard A P, Nieuwenhuijzen, Geke A P, Hospers, Johannes J, Bonenkamp, Miguel A, Cuesta, Reinoud J B, Blaisse, Olivier R C, Busch, Fiebo J W, ten Kate, Geert-Jan, Creemers, Cornelis J A, Punt, John T M, Plukker, Henk M W, Verheul, Herman, van Dekken, Maurice J C, van der Sangen, Tom, Rozema, Katharina, Biermann, Jannet C, Beukema, Anna H M, Piet, Caroline M, van Rij, Janny G, Reinders, Hugo W, Tilanus
Publikováno v:
Annals of Surgery, 260(5), 786-793. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 260, 786-92; discussion 792-3
Annals of Surgery, 260, 5, pp. 786-92; discussion 792-3
Annals of surgery, 260(5). Lippincott Williams and Wilkins
Annals of Surgery, 260, 786-92; discussion 792-3
Annals of Surgery, 260, 5, pp. 786-92; discussion 792-3
Annals of surgery, 260(5). Lippincott Williams and Wilkins
Objectives: We aimed to examine the association between total number of resected nodes and survival in patients after esophagectomy with and without nCRT.Background: Most studies concerning the potentially positive effect of extended lymphadenectomy
Autor:
Daniel P Petrylak, Ronald de Wit, Kim N Chi, Alexandra Drakaki, Cora N Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Syed Hussain, Aude Fléchon, Aristotelis Bamias, Evan Y Yu, Michiel S van der Heijden, Nobuaki Matsubara, Boris Alekseev, Andrea Necchi, Lajos Géczi, Yen-Chuan Ou, Hasan Senol Coskun, Wen-Pin Su, Miriam Hegemann, Ivor J Percent, Jae-Lyun Lee, Marcello Tucci, Andrey Semenov, Fredrik Laestadius, Avivit Peer, Giampaolo Tortora, Sufia Safina, Xavier Garcia del Muro, Alejo Rodriguez-Vida, Irfan Cicin, Hakan Harputluoglu, Ryan C Widau, Astra M Liepa, Richard A Walgren, Oday Hamid, Annamaria H Zimmermann, Katherine M Bell-McGuinn, Thomas Powles, Suet-Lai Shirley Wong, Thean Hsiang Tan, Elizabeth Jane Hovey, Timothy Dudley Clay, Siobhan Su Wan Ng, Annemie Rutten, Jean-Pascal Machiels, Herlinde Dumez, Susanna Yee-Shan Cheng, Kim Nguyen Chi, Cristiano Ferrario, Lisa Sengeloev, Niels Viggo Jensen, Constance Thibault, Brigitte Laguerre, Florence Joly, Aude Flechon, Stéphane Culine, Catherine Becht, Günter Niegisch, Michael Stöckle, Marc-Oliver Grimm, Georgios Gakis, Wolfgang Schultze-Seemann, Haralambos Kalofonos, Dimitrios Mavroudis, Christos Papandreou, Vasilis Karavasilis, Janos Révész, Lajos Geczi, Eli Rosenbaum, Raya Leibowitz-Amit, Daniel Kejzman, David Sarid, Giorgio Vittorio Scagliotti, Sergio Bracarda, Francesco Massari, Takahiro Osawa, Naoto Miyajima, Nobuo Shinohara, Fumimasa Fukuta, Chikara Ohyama, Wataru Obara, Shinichi Yamashita, Yoshihiko Tomita, Koji Kawai, Satoshi Fukasawa, Masafumi Oyama, Junji Yonese, Masayoshi Nagata, Motohide Uemura, Kazuo Nishimura, Mutsushi Kawakita, Hiroyuki Tsunemori, Katsuyoshi Hashine, Junichi Inokuchi, Akira Yokomizo, Satoshi Nagamori, Hyo Jin Lee, Se Hoon Park, Sun Young Rha, Yu Jung Kim, Yun-Gyoo Lee, Leticia Vazquez Cortés, Claudia Lorena Urzua Flores, Reinoud J B Blaisse, Fransiscus L G Erdkamp, Maureen J B Aarts, Joanna Wojcik-Tomaszewska, Piotr Tomczak, Bozena Sikora-Kupis, Michael Schenker, Alina Amalia Herzal, Anghel Adrian Udrea, Petr Karlov, Sufia Z Safina, Roman Fomkin, Enrique Grande Pulido, F Xavier García Del Muro, Juan Ignacio Delgado Mignorance, Daniel Castellano Gauna, Alejo Rodríguez-Vida, Yu-Li Su, Chien-Liang Lin, Chia-Chi Lin, Su-Peng Yeh, Irfan Çiçin, Mustafa Erman, Yuksel Urun, Yurii Golovko, Igor Bondarenko, Ivan Sinielnikov, Simon Crabb, Isabel Syndikus, Robert Huddart, Santhanam Sundar, Simon Chowdhury, Naveed Sarwar, Thomas Flaig, Chong Xian Pan, Daniel Petrylak, James Schwarz, Ivor Percent, Jennifer Cultrera, John Hainsworth, Benjamin Herms, William Lawler, Thomas Lowe, Scott Tagawa, Jeanny Aragon-Ching, Ulka Vaishampayan
Publikováno v:
Lancet (London, England), Vol. 390, no.10109, p. 2266-2277 (2017)
Lancet, 390(10109), 2266-2277. Elsevier Science
Lancet (UK), 390(10109), 2266-2277. Elsevier Ltd.
Lancet, 390(10109), 2266-2277. Elsevier Science
Lancet (UK), 390(10109), 2266-2277. Elsevier Ltd.
Summary Background Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed the efficacy and safety of treatment with docetaxel plus either ramucir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d65e42b670b576f5a3f43b55580726
https://hdl.handle.net/2078.1/275434
https://hdl.handle.net/2078.1/275434
Autor:
Renate M. Winkels, Ellen Kampman, Rianne van Lieshout, Art Vreugdenhil, Dieuwke van Barneveld, Reinoud J. B. Blaisse, Theo van Voorthuizen, Henk K. van Halteren, Laurence J.C. van Warmerdam, Jolien Hofstede, Josephina G. Kuiper, Goof Schep, Sandra Beijer
Publikováno v:
Winkels, R M, Beijer, S, van Lieshout, R, van Barneveld, D, Hofstede, J M, Kuiper, J, Vreugdenhil, A, van Warmerdam, L J C, Schep, G, Blaisse, R J B, van Voorthuizen, T, van Halteren, H & Kampman, E 2014, ' Changes in body weight during various types of chemotherapy in breast cancer patients ', e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, vol. 9, no. 1, pp. e39-e44 . https://doi.org/10.1016/j.clnme.2013.10.004
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 9(1), e39-e44. Elsevier BV
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 9(1), e39-e44
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 9 (2014) 1
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 9(1), e39-e44. Elsevier BV
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 9(1), e39-e44
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 9 (2014) 1
Background & aims: Weight gain is a common problem for breast cancer patients treated with chemotherapy. It increases the risk of several comorbidities and possibly cancer recurrence. We assessed whether weight gain depends on the type of chemotherap
Autor:
Larissa I. A. Ruczynski, Reinoud J. B. Blaisse, Katja K.H. Aben, Henk K. van Halteren, A. Visser, Hanneke W. M. van Laarhoven, Eline M. W. van de Ven
Publikováno v:
Acta Oncologica, 55, 4, pp. 423-9
Acta Oncologica, 55, 423-9
Acta oncologica (Stockholm, Sweden), 55(4), 423-429. Informa Healthcare
Acta Oncologica, 55, 423-9
Acta oncologica (Stockholm, Sweden), 55(4), 423-429. Informa Healthcare
Contains fulltext : 172075.pdf (Publisher’s version ) (Closed access) BACKGROUND: Cardiotoxicity is an important adverse effect of adjuvant breast cancer treatment with trastuzumab and three monthly left ventricular ejection fraction (LVEF) monitor